Literature DB >> 9211763

Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography.

A Flotats1, I Carrió, M Estorch, L Bernà, A M Catafau, C Marí, M Ballester.   

Abstract

A comparison was performed between technetium-99m tetrofosmin myocardial perfusion tomography at baseline and after nitrate administration, using a 2-day protocol, and rest-reinjection thallium-201 single-photon emission tomography (SPET) studies in order to assess whether nitrates enhance the detection of viable myocardium with 99mTc-tetrofosmin. Fifteen patients with coronary artery disease, previous myocardial infarction and a left ventricular ejection fraction <40% underwent 201Tl rest-injection and 99mTc-tetrofosmin baseline-postnitroglycerin (0.4 mg sublingually) SPET studies, within 48 h. Tomograms based on the three spatial planes were divided into 15 segments and regional tracer uptake was quantitatively analysed. Viability was defined as presence of tracer uptake >/=50% of peak activity on baseline studies or after reversibility. The percentage of peak activity of 99mTc-tetrofosmin at baseline correlated with that of 201Tl (r=0.82, P <0.001). On baseline 99mTc-tetrofosmin studies, 73 of the 225 segments that were analysed had <50% of peak activity. Fifteen percent of these segments showed reversibility after nitrate administration, with an increase in 99mTc-tetrofosmin uptake from 40%+/-9% to 57%+/-9% of peak activity (P=0.003). All reversible segments after nitrate administration had viability criteria on 201Tl studies, but 20 segments that were non-viable on 99mTc-tetrofosmin studies were viable on 201Tl studies. Using a threshold value of >/=40% of peak activity, only seven segments remained non-viable on 99mTc-tetrofosmin studies. Overall agreement between 99mTc-tetrofosmin with nitrates and 201Tl-reinjection regarding the presence of myocardial viability was 90%. Detection of myocardial viability with 99mTc-tetrofosmin was enhanced after nitrate administration, correlating with viability criteria observed on thallium studies.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9211763     DOI: 10.1007/bf00879665

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  8 in total

Review 1.  Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: technical, physiologic, and clinical issues.

Authors:  P Kailasnath; A J Sinusas
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

2.  FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against.

Authors:  Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

3.  Myocardial viability: strengthening the evidence base.

Authors:  Terrance Chua
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11       Impact factor: 9.236

4.  Evaluation of myocardial viability by myocardial perfusion imaging: should nitrates be used?

Authors:  Z X He; M S Verani
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

5.  Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET.

Authors:  Wei He; Wanda Acampa; Ciro Mainolfi; Francesco Menna; Anna Rita Sorrentino; Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

6.  Baseline/post-nitrate Tc-99m tetrofosmin mismatch for the assessment of myocardial viability in patients with severe left ventricular dysfunction: comparison with baseline Tc-99m tetrofosmin scintigraphy/FDG PET imaging.

Authors:  Assuero Giorgetti; Paolo Marzullo; Gianmario Sambuceti; Simona Di Quirico; Annette Kusch; Patrizia Landi; Piero Antonio Salvadori; Patrizia Pisani; Antonio L'abbate
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

7.  Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction.

Authors:  A F L Schinkel; J J Bax; F B Sozzi; E Boersma; R Valkema; A Elhendy; J R T C Roelandt; D Poldermans
Journal:  Heart       Date:  2002-08       Impact factor: 5.994

8.  Incremental prognostic value of cardiac single-photon emission computed tomography after nitrate administration in patients with ischemic left ventricular dysfunction.

Authors:  Laura Evangelista; Wanda Acampa; Mario Petretta; Adele Ferro; Francesca Ricci; Luca Luongo; Stefania Daniele; Giorgio Punzo; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.